A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9
Open accessPublished version of a preprint
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
A conformational checkpoint of Cas9 enables on-target cleavage while blocking access to the active state at off-target sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cas9/gRNA is directed to search for NGG protospacer adjacent motifs (PAMs) in the genome and if sufficient complementarity exists between the guide and the target, conformational changes occur and the now fully active Cas9 cleaves the DNA, resulting in a targeted double-stranded break (DSB)5,6.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · cited 3×
“DNA cleavage activity ofCas9 requiresMg at the catalytic site (6), yet it remains stably bound Active Inactive”
BackgroundInfluentialSelf-citationThe new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062 · cited 12×
“By manipulating the sequence of the single-guide RNA (sgRNA), Cas9-sgRNA can be programmed to target any DNA sequence flanked by a PAM (6, 8-10), making it a powerful genome editing tool.”
BackgroundInfluentialSelf-citationDevelopment and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 12×
“By manipulating the sequence of the single-guide RNA (sgRNA), Cas9-sgRNA can be programmed to target any DNA sequence flanked by a PAM (6, 8-10), making it a powerful genome editing tool.”
BackgroundInfluentialGasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673 · cited 1×
“Efforts are in progress (15, 16) to enhance the specificity of DNA targeting by Cas9 for potential therapeutic applications (17, 18), which requires detailed mechanistic understanding of substrate-dependent activation of Cas9 for DNA cleavage.”
BackgroundRationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13011 · Cited by 1,822
Self-citationStructural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
Anders, C., Niewoehner, O., Duerst, A., & Jinek, M. (2014) · Nature · doi:10.1038/nature13579 · Cited by 1,323
Cited by
Items 101–200 of 294
Exploring the Catalytic Mechanism of Cas9 Using Information Inferred from Endonuclease VII
Yoon, H., Zhao, L. N., & Warshel, A. (2018) · ACS Catalysis · doi:10.1021/acscatal.8b04324 · Cited by 34
Zuo, Z., Zolekar, A., Babu, K., Lin, V. J. T., Hayatshahi, H. S., Rajan, R., Wang, Y.-C., & Liu, J. (2019) · eLife · doi:10.7554/elife.46500 · Cited by 33
“The removal of the interfacial Mg ion from our models substantially destabilized the pseudoactive and active conformations of the Cas9-nucleic acid complex by ~600 kcal/mol (Supplementary file 1), supporting the indispensable role of the Mg ion for Cas9 conformational activation that has been previously demonstrated (…”
BackgroundResultMaghsoud, Y., Jayasinghe‐Arachchige, V. M., Kumari, P., Cisneros, G. A., & Liu, J. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01284 · Cited by 28
Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review
Ebrahimi, V., & Hashemi, A. (2020) · Gene · doi:10.1016/j.gene.2020.144813 · Cited by 33
Rational Engineering of CRISPR-Cas9 Nuclease to Attenuate Position-Dependent Off-Target Effects
Zuo, Z., Babu, K., Ganguly, C., Zolekar, A., Newsom, S. N., Rajan, R., Wang, Y.-C., & Liu, J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0076 · Cited by 32
“…DNA substrates tested in our biochemical assays encompass at most two mismatch bases and that DNA substrates bearing four more mismatches are resistant to cleavage by SpCas9, 14,38,44 we here focused on OT2, OT3, OT4, and OT7 that have a total of two or three base mismatches for analysis.”
InfluentialOrthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing
Bolukbasi, M. F., Liu, P., Luk, K., Kwok, S. F., Gupta, A., Amrani, N., Sontheimer, E. J., Zhu, L. J., & Wolfe, S. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07310-x · Cited by 31
Probing the stability of the SpCas9–DNA complex after cleavage
Aldag, P., Welzel, F., Jakob, L., Schmidbauer, A., Rutkauskas, M., Fettes, F., Grohmann, D., & Seidel, R. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1072 · Cited by 33
“While some studies have shown that SpCas9 reaches a stable, cleavage-competent ‘docked’ conformation in the presence of Mg2+ ions (14,43), other studies have observed only short excursions into the docked state with the majority of time spent in the ‘checkpoint’ conformation (15,44,45).”
Graph theory approaches for molecular dynamics simulations
Patel, A. C., Sinha, S., & Palermo, G. (2024) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583524000143 · Cited by 38
“These findings indicated that CRISPR-Cas9 achieves altered selectivity by modulating its allosteric communication, a concept that paved the way for successful engineering toward improved gene editing (Chen et al., 2017; Schmid-Burgk et al., 2020).”
How bacteria control the CRISPR-Cas arsenal
León, L. M., Mendoza, S. D., & Bondy‐Denomy, J. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.11.005 · Cited by 29
Structural basis of Staphylococcus aureus Cas9 inhibition by AcrIIA14
Liu, H., Zhu, Y., Lu, Z., & Huang, Z. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab487 · Cited by 26
Makasheva, K. A., Bryan, L. C., Anders, C., Panikulam, S., Jínek, M., & Fierz, B. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c06195 · Cited by 28
Polarity of the CRISPR roadblock to transcription
Hall, P. M., Inman, J. T., Fulbright, R. M., Le, T. T., Brewer, J. J., Lambert, G., Darst, S. A., & Wang, M. D. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00864-x · Cited by 30
Unity among the diverse RNA-guided CRISPR-Cas interference mechanisms
Ganguly, C., Rostami, S., Long, K., Aribam, S. D., & Rajan, R. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107295 · Cited by 25
“The movement of the HNH domain also removes the steric hindrance that prevents RuvC from accessing the NTS (138, 222 – 224).”
BackgroundTálas, A., Simon, D. A., Kulcsár, P. I., Varga, É., Krausz, S. L., & Welker, E. (2021) · Nature Communications · doi:10.1038/s41467-021-26461-y · Cited by 25
Murugan, K., Suresh, S. K., Seetharam, A. S., Severin, A. J., & Sashital, D. G. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab163 · Cited by 26
“Mutations rationally introduced in the REC domain of SpCas9 prevent conformational changes required for nuclease domain activation when a target sequence with mismatches is encountered (27,28).”
Wang, J., Arantes, P. R., Ahsan, M., Sinha, S., Kyro, G. W., Maschietto, F., Allen, B., Skeens, E., Lisi, G. P., Batista, V. S., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1072733 · Cited by 24
“Indeed, the rotation of the HNH domain toward activation can be modulated allosterically (Dagdas et al., 2017).”
BackgroundMachines on Genes through the Computational Microscope
Sinha, S., Pindi, C., Ahsan, M., Arantes, P. R., & Palermo, G. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.2c01313 · Cited by 27
Structural and dynamic insights into the HNH nuclease of divergent Cas9 species
Belato, H. B., D’Ordine, A. M., Nierzwicki, Ł., Arantes, P. R., Jogl, G., Palermo, G., & Lisi, G. P. (2021) · Journal of Structural Biology · doi:10.1016/j.jsb.2021.107814 · Cited by 23
Tips, Tricks, and Potential Pitfalls of CRISPR Genome Editing in Saccharomyces cerevisiae
Antony, J. S., Hinz, J. M., & Wyrick, J. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.924914 · Cited by 28
Primo, P., Meccariello, A., Inghilterra, M. G., Gravina, A., Corsano, G. D., Volpe, G., Sollazzo, G., Aceto, S., Robinson, M. D., Salvemini, M., et al. (2020) · BMC Genetics · doi:10.1186/s12863-020-00941-4 · Cited by 22
Computationally designed hyperactive Cas9 enzymes
Vos, P. D., Rossetti, G., Mantegna, J. L., Siira, S. J., Gandadireja, A. P., Bruce, M., Raven, S. A., Khersonsky, O., Fleishman, S. J., Filipovska, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30598-9 · Cited by 23
Targeting G-quadruplex Forming Sequences with Cas9
Balci, H., Globyte, V., & Joo, C. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00687 · Cited by 22
Unlocking the Potential of Chemically Modified Nucleic Acid Therapeutics
Gao, J., Nutan, B., Gargouri, D., Pisal, N. D., Do, V., Zubair, M., Alanzi, H., Wang, H., Lee, D., Joshi, N., et al. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400231 · Cited by 25
CRISPR-Cas technology for rapid detection of pathogens
Daneshgar, H., Safarkhani, M., Sojdeh, S., Bagherzadeh, M., & Rabiee, N. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118174 · Cited by 22
Mechanistic insights into the versatile class II CRISPR toolbox
Zhang, F., & Huang, Z. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.11.007 · Cited by 22
Wang, Q., Liu, J., Janssen, J. M., & Gonçalves, M. A. F. V. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad165 · Cited by 19
Raper, A. T., Stephenson, A. A., & Suo, Z. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b05469 · Cited by 20
The physicist’s guide to one of biotechnology’s hottest new topics: CRISPR-Cas
Bonomo, M. E., & Deem, M. W. (2018) · Physical Biology · doi:10.1088/1478-3975/aab6d6 · Cited by 20
Zhao, C., Wang, Y.-L., Nie, X., Han, X., Liu, H.-L., Li, G., Yang, G., Ruan, J.-X., Ma, Y.-L., Li, X.-Y., et al. (2019) · International Journal on Biological Sciences · doi:10.7150/ijbs.37152 · Cited by 9
“Further truncation of sgRNA to 15 nts can reduce DNA-binding affinity and fully abolish on-target cleavage [34].”
BackgroundEngineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles
Degtev, D., Bravo, J. P. K., Emmanouilidi, A., Zdravković, A., Choong, O. K., Touza, J. L., Selfjord, N., Weisheit, I., Francescatto, M., Akçakaya, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53418-8 · Cited by 22
Jia, Y., Guo, S., Han, Q., Zhu, J.-L., Zhang, X., Na, N., & Ouyang, J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00712b · Cited by 17
Bak, S. Y., Jung, Y., Park, J., Sung, K., Jang, H., Bae, S., & Kim, S. K. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab858 · Cited by 17
Resonator nanophotonic standing-wave array trap for single-molecule manipulation and measurement
Ye, F., Inman, J. T., Hong, Y., Hall, P. M., & Wang, M. D. (2022) · Nature Communications · doi:10.1038/s41467-021-27709-3 · Cited by 16
Javaid, N., Pham, T. L. H., & Choi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010397 · Cited by 19
Zhang, Q., Chen, Z., Wang, F., Zhang, S., Chen, H., Gu, X., Wen, F., Jin, J., Zhang, X., Huang, X., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1139 · Cited by 16
Huang, D., Liu, Y., Wang, G. A., Lv, S., Tan, Y., & Li, F. (2025) · Chemical Society Reviews · doi:10.1039/d5cs01006c · Cited by 21
Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery
He, J., Biswas, R., Bugde, P., Li, J., Liu, D., & Li, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050894 · Cited by 19
Visualizing enzyme catalytic process using single-molecule techniques
Wang, H., Zhu, C., & Li, D. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117083 · Cited by 16
AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation
Sun, W. D., Cheng, Z., Wang, J., Yang, J., Li, X., Wang, J., Chen, M., Yang, X., Sheng, G., Lou, J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303675120 · Cited by 17
Tharu, R. J., Hanson, E., & Yigit, M. V. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00355 · Cited by 14
The electronic structure of genome editors from the first principles
Nierzwicki, Ł., Ahsan, M., & Palermo, G. (2023) · Electronic Structure · doi:10.1088/2516-1075/acb410 · Cited by 15
“To determine the protonation state of the catalytic histidine residues in CRISPR-Cas9, explicit solvent CpH MD simulations were performed in conjunction with a replica exchange method [23] to enhance the sampling of the protonation states (figure 6).”
Lim, S. R., Lee, H. J., Kim, H. J., & Lee, S. J. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00323 · Cited by 14
DNA targeting by compact Cas9d and its resurrected ancestor
Ocampo, R. F., Bravo, J. P. K., Dangerfield, T. L., Nocedal, I., Jirde, S. A., Alexander, L. M., Thomas, N. C., Das, A., Nielson, S., Johnson, K. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55573-4 · Cited by 20
“These nucleases cleave the target and non-target strands using the HNH and RuvC endonuclease domains, respectively 7 .”
Understanding the Molecular Mechanisms of the CRISPR Toolbox Using Single Molecule Approaches
Singh, D., & Ha, T. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00905 · Cited by 14
Single-Molecule View of Small RNA–Guided Target Search and Recognition
Globyte, V., Kim, S. H., & Joo, C. (2018) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070317-032923 · Cited by 16
The invisible dance of CRISPR-Cas9
Palermo, G., Ricci, C. G., & McCammon, J. A. (2019) · Physics Today · doi:10.1063/pt.3.4182 · Cited by 14
Regulation of Microbial Metabolic Rates Using CRISPR Interference With Expanded PAM Sequences
Kim, B.-J., Kim, H. J., & Lee, S. J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00282 · Cited by 14
“…the field of biotechnology (Doudna and Charpentier, 2014), especially because the components of CRISPR nucleases (i.e. crRNAs and Cas proteins) are separated functionally in the recognition of target nucleotide sequences and breakage of phosphodiester bonds in nucleic acids (Dagdas et al., 2017).”
BackgroundTálas, A., Huszár, K., Kulcsár, P. I., Varga, J. K., Varga, É., Tóth, E., Welker, Z., Erdős, G., Pach, P. F., Welker, Á., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1220 · Cited by 14
“In general, the target binding of SpCas9-HF1 is not altered (32,34), rather the mutations regulate its target cleavage activity and restrict the transition of the nuclease from the conformational checkpoint during the target recognition / cleavage process (63).”
BackgroundEngineering of the genome editing protein Cas9 to slide along DNA
Banerjee, T., Takahashi, H., Subekti, D. R. G., & Kamagata, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-93685-9 · Cited by 13
Structural basis of Cas9 DNA interrogation with a 5′ truncated sgRNA
Kiernan, K. A., Kwon, J., Merrill, B. J., & Simonović, M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1164 · Cited by 13
Advances and applications of CRISPR/Cas-mediated interference in Escherichia coli
Lim, X., Zhang, C., & Chen, X. (2023) · Engineering Microbiology · doi:10.1016/j.engmic.2023.100123 · Cited by 17
Fairlamb, M. S., Whitaker, A. M., Bain, F. E., Spies, M., & Freudenthal, B. (2021) · Biology · doi:10.3390/biology10070571 · Cited by 12
Recovery of Fatty Acid Monolayers by Salts Investigated by Sum-Frequency Generation Spectroscopy
Sam, S., Krem, S., Lee, J., & Kim, D. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c08028 · Cited by 13
Kulcsár, P. I., Tálas, A., Ligeti, Z., Tóth, E., Rakvács, Z., Bartos, Z., Krausz, S. L., Welker, Á., Végi, V. L., Huszár, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41393-5 · Cited by 15
“Former studies have shown that both the mismatches and the fi delity increasing mutations in eSpCas9 and SpCas9-HF1 loosely trap SpCas9 in a catalytically inactive intermediate state and slow down the transition of the HNH domain to the active state 24,36 – 40 .”
BackgroundTaylor, D. W. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0267-1 · Cited by 12
Element coding based accurate evaluation of CRISPR/Cas9 initial cleavage
Hu, J., Liu, R., Zhou, J., & Lv, Y. (2021) · Chemical Science · doi:10.1039/d1sc03599a · Cited by 12
Unveiling Cas8 dynamics and regulation within a transposon-encoded Cascade–TniQ complex
Patel, A. C., Sinha, S., Arantes, P. R., & Palermo, G. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2422895122 · Cited by 9
“These approaches have proven instrumental in elucidating the conformational dynamics of the highly flexible HNH domain in CRISPR– Cas9 ( 25 , 26 ) and could similarly provide critical insights into the dynamics of the Cas8 bundle in the Cascade–TniQ complex.”
Genome editing in animals: an overview
Bharati, J., Punetha, M., Kumar, B. A. A. S., Vidyalakshmi, G. M., Sarkar, M., D’Occhio, M. J., & Singh, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816352-8.00003-5 · Cited by 13
Secondary Conformational Checkpoint in CRISPR-Cas9
Zhao, S., Liu, J., & Zuo, Z. (2024) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.4c00120 · Cited by 9
Kim, G. E., & Park, H. H. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae357 · Cited by 10
“Class 2 CRISPR–Cas systems, such as type II, feature a solitary effector protein called Cas9, which serves the dual function of target recognition and cleavage through interaction with a single guide RNA ( 15 ).”
BackgroundShen, P., Zhang, L., Liu, B., Li, X., Wang, C., Min, J., Huang, J., Chen, C., & Guo, R. (2024) · ACS Catalysis · doi:10.1021/acscatal.4c03278 · Cited by 9
Goolab, S., & Scholefield, J. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1464531 · Cited by 10
“…delity Cas9 variants have been engineered to reduce off-target effects, but this strategy does not completely eliminate the unintended effects and furthermore result in reduced on-target cleavage activity (Kleinstiver et al., 2016; Slaymaker et al., 2016; Chen et al., 2017; Vakulskas et al., 2018).”
BackgroundPuppulin, L., Ishikawa, J., Sumino, A., Marchesi, A. S., Flechsig, H., Umeda, K., Kodera, N., Nishimasu, H., & Shibata, M. (2023) · ACS Nano · doi:10.1021/acsnano.2c10709 · Cited by 11
Substrate-independent activation pathways of the CRISPR-Cas9 HNH nuclease
Wang, J., Maschietto, F., Qiu, T., Arantes, P. R., Skeens, E., Palermo, G., Lisi, G. P., & Batista, V. S. (2023) · Biophysical Journal · doi:10.1016/j.bpj.2023.11.005 · Cited by 8
“When the base-pairs between tDNA and gRNA are incomplete, the full twisting motion of HNH is not achieved, and the RuvC active site is not fully assembled (10,11).”
BackgroundTOPO-seq reveals DNA topology-induced off-target activity by Cas9 and base editors
Duan, M., Gao, P., Zhang, Y.-Z., Hu, Y.-L., Zhou, L., Xu, Z.-C., Qiu, H.-Y., Tong, X., Ji, R.-J., Lei, X.-L., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01867-7 · Cited by 9
“…Nature Portfolio reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at https://doi.org/10.1038/s41589-025-01867-7.”
InfluentialHanson, E., Gold, R., Lee, D. H., & Yigit, M. V. (2026) · ACS Sensors · doi:10.1021/acssensors.5c04848 · Cited by 9
CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis
Gu, B., Li, M., Li, D., & Huang, K. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10587-7 · Cited by 16
Sortase-mediated fluorescent labeling of CRISPR complexes
Dillard, K. E., Schaub, J. M., Brown, M. W., Saifuddin, F. A., Xiao, Y., Hernandez, E. T., Dahlhauser, S. D., Anslyn, E. V., Ke, A., & Finkelstein, I. J. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.031 · Cited by 9
Hoque, M. E., Mustafa, G., Basu, S., & Balci, H. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00067 · Cited by 11
Li, Y., Liu, Y., Singh, J. K., Tangprasertchai, N. S., Trivedi, R., Fang, Y. H., & Qin, P. Z. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0100 · Cited by 9
“17 Studies with 20 nt full-length guides containing mismatches also have linked DNA unwinding to Cas9 cleavage rate.”
InfluentialPan, J., Mabuchi, M. Y., & Robb, G. B. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad233 · Cited by 9
“Substrate 2 has a shortened ntsDNA in the PAM distal region and was designed based on a previous report (35) that reaction of a similar substrate with SpyCas9 resulted in fast release of the PAM distal ntsDNA.”
Mutational rescue of the activity of high-fidelity Cas9 enzymes
Vos, P. D., Gandadireja, A. P., Rossetti, G., Siira, S. J., Mantegna, J. L., Filipovska, A., & Rackham, O. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100756 · Cited by 12
Dynamic sampling of a surveillance state enables DNA proofreading by Cas9
Paula, V. S. D., Dubey, A., Arthanari, H., & Sgourakis, N. G. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.10.001 · Cited by 8
A simple and rapid method for enzymatic synthesis of CRISPR-Cas9 sgRNA libraries
Yates, J. D., Russell, R. C., Barton, N., Yost, H. J., & Hill, J. T. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab838 · Cited by 9
Single Molecule FRET Analysis of CRISPR Cas9 Single Guide RNA Folding Dynamics
Okafor, I. C., & Ha, T. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c05428 · Cited by 8
A study on endonuclease BspD6I and its stimulus-responsive switching by modified oligonucleotides
Abrosimova, L. A., Migur, A. Y., Kubareva, E. A., Zatsepin, T. S., Gavshina, A. V., Yunusova, A. K., Perevyazova, T. A., Pingoud, A. M., & Oretskaya, T. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207302 · Cited by 8
Structural basis of Cas12a R-loop propagation on pathway to DNA cleavagePreprint
Strohkendl, I., Moy, C., Nguyen, A.-H., Russell, R., & Taylor, D. W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.13.532460 · Cited by 8
Krausz, S. L., Simon, D. A., Bartos, Z., Biczók, Z., Varga, É., Huszár, K., Kulcsár, P. I., Tálas, A., Ligeti, Z., & Welker, E. (2025) · Nature Catalysis · doi:10.1038/s41929-025-01406-6 · Cited by 9
“…PE likely because the prime editor complex is inactive and uses a short spacer, ensuring a more dynamic exchange of the tpgRNAs on the target DNA 39–42 , therefore providing a greater chance of delivering an intact PBS within the appropriate time period during which the nicked non-target strand…”
Structural basis of supercoiling-induced CRISPR–Cas9 off-target activity
Smith, Q. M., Whittle, S., Aramayo, R. J., Rollins, D. E., Jalal, A. S. B., Egharevba, D. I., Morris, K. L., Pyne, A. L. B., & Rueda, D. (2026) · Nature · doi:10.1038/s41586-026-10255-7 · Cited by 10
“In agreement with our on-target structure and previous smFRET data 12 , the bound dCas9 complex exhibits a clear high (~0.7) FRET ratio (Fig.”
InfluentialMolecular mechanisms and biotechnology applications of CRISPR–Cas12a
Saha, A., Ocampo, R. F., Wright, J. T., Taylor, D. W., & Palermo, G. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-026-00969-x · Cited by 13
Genome im Fokus: Entwicklung und Anwendungen von CRISPR‐Cas9‐Bildgebungstechnologien
Knight, S. C., Tjian, R., & Doudna, J. A. (2017) · Angewandte Chemie · doi:10.1002/ange.201709201 · Cited by 7
Self-citationWen, S., Zhao, Y., Qi, X., Cai, M., Huang, K., Liu, H., & De, K. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.12.030 · Cited by 7
“Previous experimental studies revealed that the HNH domain transitions between multiple conformations before recognizing its on-target DNA, which can help HNH accurately dock into its active state [39,40].”
Single-molecule perspectives of CRISPR/Cas systems: target search, recognition, and cleavage
Lee, J., & Jeong, C. (2025) · BMB Reports · doi:10.5483/bmbrep.2024-0182 · Cited by 7
Dissecting Structure and Function of DNA·RNA Hybrids
Palermo, G. (2019) · Chem · doi:10.1016/j.chempr.2019.05.015 · Cited by 7
Modulating Cas9 activity for precision gene editing
Uslu, M., Siyah, P., Harvey, A. J., & Kocabaş, F. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.015 · Cited by 7
A Review: Computational Approaches to Design sgRNA of CRISPR-Cas9
Nasir, M. A., Nawaz, S., & Huang, J. H. (2021) · Current Bioinformatics · doi:10.2174/1574893616666210601105553 · Cited by 7
Complex dependence of CRISPR-Cas9 binding strength on guide RNA spacer lengths
Khakimzhan, A., Garenne, D., Tickman, B. I., Fontana, J. T., Carothers, J. M., & Noireaux, V. (2021) · Physical Biology · doi:10.1088/1478-3975/ac091e · Cited by 8
Single-molecule FRET studies of Cas9 endonuclease
Globyte, V., & Joo, C. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.11.002 · Cited by 8
Bridge helix of Cas12a is an allosteric regulator of R-loop formation and RuvC activation
Ganguly, C., Aribam, S. D., dos Santos, A. M., Martin, L., Thomas, L. M., Shao, Y., & Rajan, R. (2026) · Nature Communications · doi:10.1038/s41467-026-68657-0 · Cited by 7
“4d and Supplementary Tables 13, 16, and 19).”
Molecular mechanisms of Streptococcus pyogenes Cas9: a single-molecule perspective
Zhang, Q., Chen, Z., & Sun, B. (2021) · Biophysics Reports · doi:10.52601/bpr.2021.210021 · Cited by 6
“… the investigation of nearly all catalytic steps of © The Author(s) 2021 477 | December 2021 | Volume 7 | Issue 6 SpCas9 (Table 1) (Bak et al. 2021; Chen et al. 2017; Dagdas et al. 2017; Globyte et al. 2019; Lim et al. 2016; Okafor et al. 2019; Osuka et al. 2018; Singh et…”
Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAs
Ma, S., Lv, J., Feng, Z., Rong, Z., & Lin, Y. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3377 · Cited by 8
“When it is truncated down to 15 nucleotides, the sgRNA becomes inactive with respect to cleavage activity (so-called “dead sgRNA”/dRNA), at the same time as retaining its genomic targeting capacity.(79,80) Based on dRNA, wildtype Cas9 can regulate gene transcription by fusing with potent transcriptional activators (VP…”
BackgroundSingle molecule methods for studying CRISPR Cas9-induced DNA unwinding
Okafor, I. C., Choi, J., & Ha, T. (2021) · Methods · doi:10.1016/j.ymeth.2021.11.003 · Cited by 9
And… cut! – how conformational regulation of CRISPR-Cas effectors directs nuclease activity
Calvert, R. W., & Knott, G. J. (2025) · Biochemical Journal · doi:10.1042/bcj20240481 · Cited by 6
“Crossing the ~16 bp threshold elongates the target-sgRNA heteroduplex (along with ssDNA from the NTS) to trigger the HNH adopting an active state [26,46,47].”
Improved CRISPR/Cas9 off-target prediction with DNABERT and epigenetic features
Kimata, K., & Satou, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335863 · Cited by 7
A mechanistic study on the tolerance of PAM distal end mismatch by SpCas9
Dey, D., Chakravarti, R., Bhattacharjee, O., Majumder, S., Chaudhuri, D., Kazi, T. A., Roy, D., Bhattacharya, B., Arya, M., Gautam, A., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107439 · Cited by 5
“A single base loss ( via mismatch or deletion) is poorly tolerated when the probe length is 17 nucleotides (40).”
BackgroundKumar, A., Daripa, P., Rasool, K., Chakraborty, D., Jain, N., & Maiti, S. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c04044 · Cited by 4
Weiditch, S. A., Bickers, S. C., Bona, D., Maxwell, K. L., & Kanelis, V. (2020) · Journal of Bacteriology · doi:10.1128/jb.00644-19 · Cited by 5
“Notably, the activating conformational changes in the HNH domain that allow it to bind the target strand are dependent on divalent metal binding (55).”
BackgroundHideRNAs protect against CRISPR-Cas9 re-cutting after successful single base-pair gene editing
Harmsen, T., Pritchard, C. E. J., Riepsaame, J., van de Vrugt, H. J., Huijbers, I. J., & Riele, H. T. (2022) · Scientific Reports · doi:10.1038/s41598-022-13688-y · Cited by 4
Visualization of a multi-turnover Cas9 after product release
Kiernan, K. A., & Taylor, D. W. (2025) · Nature Communications · doi:10.1038/s41467-025-60668-7 · Cited by 6
“A previous single-molecule FRET (smFRET) study has shown that following DNA cleavage, HNH adopts the conformationalcheckpoint state again 55 , but was later confounded by a separate smFRET study showing HNH is highly fl exible following cleavage 56 .”
Genetically modified helminths as pharmaceutical biofactories
Walther, D., Smout, M. J., Giacomin, P., Brindley, P. J., Mitreva, M., Moyle, M., & Loukas, A. C. (2025) · Advances in Parasitology/Advances in parasitology · doi:10.1016/bs.apar.2025.08.001 · Cited by 6
Metadata
- Authors
- Dagdas, Y. S., Chen, J. S., Sternberg, S. H., Doudna, J. A., & Yildiz, A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science Advances
- Published
- 2017-08-04
- Volume
- 3
- Issue
- 8
- Pages
- eaao0027-eaao0027
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC5547770
- OpenAlex
- W2953019923
- Semantic Scholar
- 7c14118bfa45dd74655e44e80fecd2190ee7c008
- Cited by
- 293
- References
- 32
- Citations by year
- 2026: 24 · 2025: 33 · 2024: 31 · 2023: 30 · 2022: 29 · 2021: 37 · 2020: 36 · 2019: 34 · 2018: 25 · 2017: 14
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Science Advances (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Science Foundation (award336915, Graduate Research Fellowship, award336918, MCB-1055017, award336919, MCB-1244557)
- National Institutes of Health (award336916, GM094522)
- Howard Hughes Medical Institute (award336920)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, HNH endonuclease, DNA binding, DNA cleavage, guide RNA, sequence mismatches, off-target cleavage, divalent cations, protein-DNA docking, genome editing
- MeSH terms
- Protein Domains, Gene Editing, RNA, Guide, CRISPR-Cas Systems, DNA, Molecular Conformation, Structure-Activity Relationship, Fluorescence Resonance Energy Transfer, DNA Cleavage, Molecular Dynamics Simulation, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.